| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA758141 | F | Antitumor activity of vincristine against P388/VCR leukemia in mice at a dose of 100 mg/kg | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 2. | ALA758142 | F | Antitumor activity of vincristine against P388/VCR leukemia in mice at a dose of 100 mg/kg. | Mus musculus | 10 | organism-based format | Scientific Literature | ||
| 3. | ALA758143 | F | Antitumor activity of vincristine against P388/VCR leukemia in mice at a dose of 50 mg/kg | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 4. | ALA758144 | F | Antitumor activity of vincristine against P388/VCR leukemia in mice at a dose of 50 mg/kg. | Mus musculus | 10 | organism-based format | Scientific Literature | ||
| 5. | ALA3231576 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.08 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 6. | ALA3231907 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.80 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 7. | ALA3231908 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.648 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 8. | ALA3231909 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.00 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA3231910 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA3231911 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.36 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA3231912 | F | Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 12. | ALA3231913 | F | Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.90 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 13. | ALA3231914 | F | Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 0.60 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 14. | ALA3783840 | F | Cytotoxicity against mouse P388/VCR cells after 72 hrs by coulter counting analysis | Mus musculus | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!